William Ryan

Investor Relations Contact at Rapid Pathogen Screening, Inc.

Health Services

Health Technology

Profile

William Ryan is currently the Vice President-Corporate Relations at Rapid Pathogen Screening, Inc. since 2007.
Prior to this, he worked as a Principal at Celleration, Inc.

William Ryan active positions

Companies	Position	Start
Rapid Pathogen Screening, Inc. Rapid Pathogen Screening, Inc. Medical/Nursing ServicesHealth Services Rapid Pathogen Screening, Inc. is an emerging biotechnology company strategically focused on designing, developing, and delivering novel point-of-care tests for infectious diseases and inflammatory conditions as well as bio-terrorism and chemical nerve agent blood toxins. The firm’s products include AdenoPlus, InflammaDry, FebriDx. The company was founded by Robert P. Sambursky and Robert W. VanDine in 2004 and is headquartered in Sarasota, FL.	Investor Relations Contact	-

All active positions of William Ryan

Former positions of William Ryan

Companies	Position	End
Celleration, Inc. Celleration, Inc. Medical SpecialtiesHealth Technology Celleration, Inc. manufactured medical devices. It developed and marketed a proprietary technology to accelerate healing in wounds by delivering therapeutic, low frequency ultrasound without direct contact of the delivery device to the wound surface. The firm’s core product was the MIST Therapy System, impacted all critical aspects of the wound healing process providing clinical and economic benefits to institutions treating nonresponding wounds. The company was founded by Gene Berghoff, Dennis L. Davey and Eliaz P. Babaev in 1999 and was headquartered in Eden Prairie, MN.	Corporate Officer/Principal	-

See the detail of William Ryan's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of William Ryan's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Rapid Pathogen Screening, Inc. Rapid Pathogen Screening, Inc. Medical/Nursing ServicesHealth Services Rapid Pathogen Screening, Inc. is an emerging biotechnology company strategically focused on designing, developing, and delivering novel point-of-care tests for infectious diseases and inflammatory conditions as well as bio-terrorism and chemical nerve agent blood toxins. The firm’s products include AdenoPlus, InflammaDry, FebriDx. The company was founded by Robert P. Sambursky and Robert W. VanDine in 2004 and is headquartered in Sarasota, FL.	Health Services
Celleration, Inc. Celleration, Inc. Medical SpecialtiesHealth Technology Celleration, Inc. manufactured medical devices. It developed and marketed a proprietary technology to accelerate healing in wounds by delivering therapeutic, low frequency ultrasound without direct contact of the delivery device to the wound surface. The firm’s core product was the MIST Therapy System, impacted all critical aspects of the wound healing process providing clinical and economic benefits to institutions treating nonresponding wounds. The company was founded by Gene Berghoff, Dennis L. Davey and Eliaz P. Babaev in 1999 and was headquartered in Eden Prairie, MN.	Health Technology